Correlation Between Dianthus Therapeutics and Evotec SE

Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Evotec SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Evotec SE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dianthus Therapeutics and Evotec SE ADR, you can compare the effects of market volatilities on Dianthus Therapeutics and Evotec SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Evotec SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Evotec SE.

Diversification Opportunities for Dianthus Therapeutics and Evotec SE

-0.72

Correlation Coefficient

Dianthus Therapeutics  Evotec SE

Pay attention - limited upside

The 3 months correlation between Dianthus and Evotec is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Evotec SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evotec SE ADR and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Evotec SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evotec SE ADR has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Evotec SE go up and down completely randomly.

Pair Corralation between Dianthus Therapeutics and Evotec SE

Given the investment horizon of 90 days Dianthus Therapeutics is expected to under-perform the Evotec SE. But the stock apears to be less risky and, when comparing its historical volatility, Dianthus Therapeutics is 1.6 times less risky than Evotec SE. The stock trades about -0.05 of its potential returns per unit of risk. The Evotec SE ADR is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  335.00  in Evotec SE ADR on September 24, 2024 and sell it today you would earn a total of  112.00  from holding Evotec SE ADR or generate 33.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Dianthus Therapeutics  vs.  Evotec SE ADR

Dianthus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Evotec SE ADR

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Evotec SE ADR are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Evotec SE displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Dianthus Therapeutics and Evotec SE

The main advantage of trading using opposite Dianthus Therapeutics and Evotec SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Evotec SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will offset losses from the drop in Evotec SE's long position.

The idea behind Dianthus Therapeutics and Evotec SE ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.